Anrs, Emerging Infectious Diseases

This study looks at whether giving an Ebola vaccine (Ervebo) together with an antibody drug (Inmazeb) still protects people from Ebola. The vaccine takes time to work, while the antibody acts fast, so combining them might offer better protection. About 132 healthy adults will tak…

This study tests whether giving a vaccine plus an antibody drug right after high-risk Ebola exposure works better than the vaccine alone. It involves 160 people who have had close contact with an Ebola patient. The goal is to see which approach prevents more people from getting s…

This study looks at how long the immune system remembers the mpox virus after someone gets infected. Researchers will check blood samples from 60 adults who had mpox to see if they still have protective antibodies and memory B cells. The goal is to understand if past infection gi…

This study will follow 4000 children in Cambodia to understand how common Japanese Encephalitis virus infections are, both in healthy kids and those hospitalized with fever and brain symptoms. Researchers will test blood samples to measure infection rates and look for risk factor…

This study looks at frailty and other age-related health problems in 600 older adults (60+) in Burkina Faso, Côte d'Ivoire, and Togo. Half have HIV, half do not. Researchers want to see if HIV speeds up aging and find better ways to screen for and manage these issues. The goal is…

This study will follow over 5,000 pregnant women with HIV, hepatitis B, C, or arbovirus infections and their children for up to 7 years. Researchers want to learn how these viruses and their treatments affect pregnancy, the mother's health, and the child's development. The goal i…